Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers A > Headlines for ABN Amro Bank NV > News item |
ABN Amro to price 9% reverse convertibles linked to Astrazeneca
By Laura Lutz
Washington, March 5 - ABN Amro Bank NV plans to price an issue of 9% reverse convertible notes due March 7, 2008 linked to American Depositary Shares of Astrazeneca plc, according to a 424B2 filing with the Securities and Exchange Commission.
Interest will be payable monthly.
The payout at maturity will be par unless Astrazeneca ADRs fall below the knock-in price - 80% of the initial share price - during the life of the notes and finish below the initial share price, in which case the payout will be a number of Astrazeneca ADRs equal to $1,000 divided by the initial share price.
The notes will price on March 6 and settle on March 9.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.